Auckland
New Zealand
University of Auckland - Faculty of Medical and Health Sciences
rheumatic fever, T cell dysregulation, CXCR3, immune-modulating therapy, CCL5, IgG3
Rheumatic fever, Rheumatic heart disease, Risk factors, Case-control study, epidemiology, Household crowding, Healthcare access, Group A Streptococcus, Sore throat, Skin infection, New Zealand
Group A Streptococcus, rheumatic fever, IgG3, biomarker, M-protein, interleukin-6